Metformin Lowers Blood Sugar by Targeting Gut, Not Liver, Northwestern Study in Mice Finds

AI Summary

A Northwestern study has found that Metformin reduces blood sugar by primarily targeting the gut rather than the liver, which may have implications for diabetes treatment strategies. This research advances our understanding of the medication's effects in managing blood glucose levels.